Loomis Financial November Newsletter

When you start a job, you can usually either choose a super fund or let your employer choose for you.

Read full article >>

Superannuation fund members have experienced a rollercoaster ride this year as extreme volatility on financial markets has seen investment returns rise and fall, often quite acutely, on an ongoing basis.

Read full article >>

Diversification is an investment strategy that lowers your portfolio's risk and helps you get more stable returns.

Read full article >>

You’ve spent decades working, so you don’t want to spend your retirement years scrimping for cash.

How can you make sure that doesn’t happen?

Read full article >>

While many of us dream about the day we finally get to give up work and reap the benefits of our blood, sweat and tears, we often struggle to plan for it.

Read full article >>

Should you worry if your super balance is fluctuating? Or is it a sign that you’ve got the right long-term, growth-oriented approach to your super.

Read full article >>

To no one’s surprise, there has been renewed interest in government bonds in recent months, considered safe havens during troubled times.

Read full article >>

Lower tax on your investments can help you reach your financial goals sooner. But don't choose an investment based on tax benefits alone.

Read full article >>

• Senator Biden is projected to win the US presidency, while President Trump’s chances hinge on successful legal challenges in multiple battleground states.

• Markets were buoyed in November by the successful trial of the Pfizer/BioNtech vaccine, which is expected to be approved by the FDA later in the month.

• Rising COVID-19 cases in Europe have forced countries to return to lockdown conditions, including the closure of non-essential businesses.

• After bouncing back from the pandemic, China revealed its new five-year plan, which continues China’s focus on emerging technology and innovation.

• Australia’s combined fiscal and monetary response, along with the easing of restrictions across the country, are expected to boost the recovery in the final quarter of 2020.

Global economies

Data from the World Health Organisation showed confirmed COVID-19 cases worldwide were above 45 million at the end of October and global deaths were 1.2 million. According to the IMF, the global growth rate is forecast to be a significantly negative figure of -4.4% for 2020, bouncing back to 5.2% in 2021, although recovery is expected to be “uneven and uncertain”.

US

The economic data point to ongoing strength in the US recovery but record daily cases of COVID-19 are dragging on sentiment.

Europe

The UK broadened the number of cities under the highest tier restrictions, while Germany and France announced heightened restrictions to prevent an uncontrolled outbreak. Eurozone GDP for the September quarter came in stronger than expected at 12.7%

China

China unveiled its 14th five-year plan, outlining its economic and social priorities for 2021-25. The plan is centred around maintaining economic growth, with technology and innovation again a key focus, especially strategic emerging sectors like biotechnology, semiconductors and new energy vehicles.

Asia Region

India became the second country to pass 8 million COVID-19 cases in October, fast approaching the US, which ticked over 9 million at the start of November.

Australia

With a string of zero daily cases, the Victorian Premier Daniel Andrews announced an easing of restrictions, including the removal of the 25km ‘ring of steel’ around Melbourne and a further relaxing of rules around social gatherings and businesses. NSW Premier Gladys Berejiklian announced the reopening of the NSW-Victoria border on 23 November, with all requirements for border permits and quarantine removed.

If you have any questions regarding this report or would like to discuss your portfolio, please call our office on 02 6562 2295.

Read the full November 2020 market update report  >>

The information in this Market Update is current as at 9/10/2020 and is prepared by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421445 on behalf of National Australia Bank and its subsidiaries. Any advice in this Market Update has been prepared without taking account of your objectives, financial situation or needs. Before making any decisions based on the content of this document, the reader must consider whether it is personally appropriate in light of his or her financial circumstances or should seek independent financial advice on its appropriateness. Past performance is not a reliable indicator of future performance. Before acquiring a financial product, you should obtain and read the corresponding Product Disclosure Statement (PDS) and consider the contents of the PDS before making a decision about whether to acquire the product.